Concepedia

Oliver Pagel

OP

Statistics

Publications

6

Citations

168

H-Index

6

Active since

2017

Affiliations

Leibniz Institute for Analytical Sciences - ISAS(Current)

Johannes Gutenberg University Mainz

University Medical Center of the Johannes Gutenberg University Mainz

Jewish General Hospital

University College Dublin

Oliver Pagel is an author at Leibniz Institute for Analytical Sciences - ISAS specializing in life sciences, platelet activation, and cell signaling.

ORCID

Publications per year

2017–2021

6

Publications

6

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors

Dennis Plenker, M Riedel, Johannes Brägelmann et al. · Science Translational Medicine · 2017 · 64 citations · Full text

, , +12

Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS

Frauke Swieringa, Fiorella A. Solari, Oliver Pagel et al. · Scientific Reports · 2020 · 27 citations · Full text

, , +15

The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets

Elena Kumm, Oliver Pagel, Stepan Gambaryan et al. · Cells · 2020 · 26 citations · Full text

, , +17

The RhoA regulators Myo9b and GEF‐H1 are targets of cyclic nucleotide‐dependent kinases in platelets

Shane P. Comer, Zoltán Nagy, Alex von Kriegsheim et al. · Journal of Thrombosis and Haemostasis · 2020 · 22 citations · Full text

, , +14

Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications

G. Todd Milne, Peter Sandner, Kathleen Lincoln et al. · BMC Pharmacology and Toxicology · 2017 · 16 citations · Full text

, , +13

1–5 of 6